Personalized matching to breast cancer clinical trials (BCT) is a patient-centered website designed to increase public awareness and access to clinical trials. Launched in 2008, following a successful UCSF-NCI sponsored research pilot, its mission is to make patient consideration of trials the norm vs. the exception. We believe that all patients should have access to the latest medical knowledge about breast cancer treatment as well as the opportunity to advance breast cancer research.

BCT features online tools to help patients find trials personalized to their situation. These include:

  • BCT Match: Personalized matching to trials based on a user’s self-reported diagnostic and treatment history; users find trials for which they are most likely to be eligible.
  • BCT Browse: Provides links to groups of trials organized by: Category such as targeted therapy or immunotherapy; or Tumor Type such as newly diagnosed or metastatic disease.
  • Metastatic Trial Search (MTS): Powered by BCT and in collaboration with five breast cancer advocacy groups, MTS is embedded on each organization's website. It was launched in October 2015 and funded by the Avon-Pfizer Metastatic Grant Program.
  • Metastatic Trial Talk (MTT): Designed as a companion to MTS, MTT is a one-stop shop for MBC patients seeking accurate and unbiased content (news, information, and resources) about metastatic breast cancer research from trusted online sources.

Operating as a non-profit service, BCT lists over 600 studies for people with newly diagnosed breast cancer, metastatic disease, or post-treatment survivors. It includes innovative trials of targeted and immunotherapies as well as observational studies looking at quality of life, genetic mutations, and breast cancer survivorship, accompanied by easy-to-read trial summaries.

For more information, contact the BCT Helpdesk at (888) 282-7099 or

Visit to learn more